Cecilia Furlong
Stock Analyst at Morgan Stanley
(0)
# 4076
Out of 5,291 analysts
207
Total ratings
45.71%
Success rate
-7.49%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Nevro | Downgrades: Underweight | 9 4 | 5.85 | -31.62% | 9 | Dec 2, 2024 | |
Intuitive Surgical | Upgrades: Overweight | 522 650 | 491.6 | 32.22% | 13 | Dec 2, 2024 | |
Sight Sciences | Maintains: Equal-Weight | 7 5 | 2.55 | 96.08% | 15 | Nov 11, 2024 | |
Embecta | Maintains: Underweight | 13 12 | 12.29 | -2.36% | 12 | Jul 15, 2024 | |
iRhythm Technologies | Maintains: Overweight | 135 130 | 105.05 | 23.75% | 15 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 130 120 | 112.23 | 6.92% | 11 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 75 95 | 68.47 | 38.75% | 12 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 104 98 | 87.61 | 11.86% | 9 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 76 69 | n/a | n/a | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 83 83 | n/a | n/a | 10 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 1 | n/a | n/a | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 78 85 | 95.86 | -11.33% | 9 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 224 291 | n/a | n/a | 6 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 15 | 24.25 | -38.14% | 4 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 325 343 | 258.63 | 32.62% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 14 | 6.82 | 105.28% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 44 48 | 33.76 | 42.18% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 95 102 | 70.9 | 43.86% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 56 58 | 99.27 | -41.57% | 16 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 18 20 | 14.18 | 41.04% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 117 131 | 67.69 | 93.53% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 117 133 | 130.82 | 1.67% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 235 380 | n/a | n/a | 2 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 270 220 | 364.44 | -39.63% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 383 378 | 137.75 | 174.41% | 2 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 29 25 | n/a | n/a | 3 | Jan 7, 2022 |